Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropisetron in Chronic Musculoskeletal Pain
NCT00889499Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Mar 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tropisetron in chronic musculoskeletal pain (3 arms), sponsored by Insel Gruppe. Primary endpoint: Pain intensity (VAS score) at 2 hours. Started Mar 2009; status: completed.
02
Drugs
tropisetron
03
Conditions
chronic musculoskeletal pain
Beyond the preview
Go deeper on NCT00889499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889499.